Key result
Oral terbutaline successfully treats symptomatic postpartum sinus bradycardia, avoiding permanent pacemaker implantation.
Why the study?
Postpartum sinus bradycardia is an uncommon clinical entity primarily described in isolated case reports and small case series, with limited treatment data.
Does oral terbutaline effectively treat symptomatic postpartum sinus bradycardia and avoid the need for permanent pacemaker implantation?
Does oral terbutaline effectively treat symptomatic postpartum sinus bradycardia and avoid the need for permanent pacemaker implantation?
Oral terbutaline may serve as an effective medical therapy for transient symptomatic postpartum sinus bradycardia, potentially preventing unnecessary permanent pacemaker implantations.
May represent benign vagal response postpartum; leaves open need for systematic studies on incidence and management.
Postpartum sinus bradycardia is an uncommon clinical entity that has been described primarily in isolated case reports and small case series. The postpartum period is characterized by rapid hormonal withdrawal and autonomic recalibration, which may result in transient increases in vagal tone and clinically significant sinus bradycardia.
No takes yet. Share an insight, caveat, or question.
Yousefian et al. (2026) studied this question. Oral terbutaline successfully treated reversible symptomatic postpartum sinus bradycardia, avoiding the need for permanent pacemaker implantation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: